• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高危手术患者致命性肺栓塞一级和二级预防的成本效益

Cost-effectiveness of primary and secondary prevention of fatal pulmonary embolism in high-risk surgical patients.

作者信息

Hull R D, Hirsh J, Sackett D L, Stoddart G L

出版信息

Can Med Assoc J. 1982 Nov 15;127(10):990-5.

PMID:6182968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1862293/
Abstract

Because death due to pulmonary embolism is relatively rare following general surgery, many question the need for prophylaxis. In addition, there has been reluctance to apply new interventions whose cost-effectiveness has not been adequately evaluated. A cost-effectiveness analysis based on over 1000 high-risk patients undergoing abdominothoracic surgery, with effectiveness measured in terms of numbers of deaths from pulmonary embolism averted, has shown subcutaneous administration of heparin in low doses starting 2 hours before the operation to be the most cost-effective of several active approaches to prophylaxis. It averted seven of the eight deaths expected without active prophylaxis per 1000 such patients and cost half as much as the traditional approach of intervening only when venous thromboembolism becomes clinically apparent. Intravenous administration of dextran, although effective, was expensive, and leg scanning with iodine-125-labelled fibrinogen was extremely expensive. Intermittent pneumatic compression of the legs was inexpensive, but, as with leg scanning, its effectiveness has not been determined in randomized trials.

摘要

由于普通外科手术后因肺栓塞导致的死亡相对较少,许多人质疑预防的必要性。此外,人们一直不愿意采用那些成本效益尚未得到充分评估的新干预措施。一项基于1000多名接受胸腹手术的高危患者的成本效益分析表明,以避免肺栓塞死亡人数来衡量有效性,在手术前2小时开始皮下注射低剂量肝素是几种积极预防方法中最具成本效益的。每1000名此类患者中,它避免了预期的8例死亡中的7例,且成本仅为传统方法(仅在静脉血栓栓塞出现临床症状时才进行干预)的一半。静脉注射右旋糖酐虽然有效,但成本高昂,而用碘-125标记的纤维蛋白原进行腿部扫描则极其昂贵。间歇性腿部充气压迫成本低廉,但是,与腿部扫描一样,其有效性尚未在随机试验中得到确定。

相似文献

1
Cost-effectiveness of primary and secondary prevention of fatal pulmonary embolism in high-risk surgical patients.高危手术患者致命性肺栓塞一级和二级预防的成本效益
Can Med Assoc J. 1982 Nov 15;127(10):990-5.
2
The prevention of postoperative deep vein thrombosis and pulmonary embolism with low dose subcutaneous heparin and dextran.低剂量皮下注射肝素和右旋糖酐预防术后深静脉血栓形成和肺栓塞
Surg Gynecol Obstet. 1976 Dec;143(6):981-5.
3
Prevention of venous thromboembolism.静脉血栓栓塞的预防
Semin Thromb Hemost. 1976 Apr;2(4):232-90. doi: 10.1055/s-0028-1086126.
4
Prevention of postoperative venous thromboembolism by external pneumatic calf compression in patients with gynecologic malignancy.
Obstet Gynecol. 1984 Jan;63(1):92-8.
5
Dextran 70 in prophylaxis of thromboembolic disease after surgery: a clinically oriented randomized double-blind trial.右旋糖酐70预防术后血栓栓塞性疾病:一项临床导向的随机双盲试验。
Br Med J. 1975 Apr 19;2(5963):109-12. doi: 10.1136/bmj.2.5963.109.
6
Prevention of postoperative thromboembolism by dextran 70 or low-dose heparin.右旋糖酐70或低剂量肝素预防术后血栓栓塞
Obstet Gynecol. 1980 Apr;55(4):497-500.
7
Effect of intravenous dextran 70 and pneumatic leg compression on incidence of postoperative pulmonary embolism.
Br Med J. 1976 Nov 27;2(6047):1281-4. doi: 10.1136/bmj.2.6047.1281.
8
Labelled fibrinogen in the study of deep venous thrombosis.深静脉血栓形成研究中的标记纤维蛋白原。
Recent Adv Clin Nucl Med. 1975;1:129-50.
9
Current concepts. Relation between deep vein thrombosis and pulmonary embolism in surgical patients.当前概念。外科手术患者深静脉血栓形成与肺栓塞之间的关系。
N Engl J Med. 1974 Dec 12;291(24):1292-4. doi: 10.1056/NEJM197412122912407.
10
[The case for more active prevention of deep-vein thrombosis after major surgery (author's transl)].关于更积极预防大手术后深静脉血栓形成的理由(作者译)
Acta Chir Belg. 1976 Jul;75(4):402-15.

引用本文的文献

1
Efficacy and safety profiles of mechanical and pharmacological thromboprophylaxis.机械性和药物性血栓预防的疗效与安全性概况
Ann Transl Med. 2019 Sep;7(Suppl 6):S224. doi: 10.21037/atm.2019.08.44.
2
Can thrombus age guide thrombolytic therapy?血栓的形成时间能否指导溶栓治疗?
Cardiovasc Diagn Ther. 2017 Dec;7(Suppl 3):S186-S196. doi: 10.21037/cdt.2017.11.05.
3
Accounting for the relationship between per diem cost and LOS when estimating hospitalization costs.当估计住院费用时,考虑每日费用与住院日数之间的关系。
BMC Health Serv Res. 2012 Dec 1;12:439. doi: 10.1186/1472-6963-12-439.
4
Venous thromboembolism in Pakistan: a neglected research agenda.巴基斯坦的静脉血栓栓塞症:被忽视的研究议程。
J Thromb Thrombolysis. 2013 Feb;35(2):234-42. doi: 10.1007/s11239-012-0799-2.
5
Use of venous thromboprophylaxis and adherence to guideline recommendations: a cross-sectional study.静脉血栓预防措施的使用及对指南建议的遵循情况:一项横断面研究
Thromb J. 2004 Apr 1;2(1):3. doi: 10.1186/1477-9560-2-3.
6
Formulary management of low molecular weight heparins.低分子量肝素的处方集管理
Pharmacoeconomics. 2000 Jan;17(1):1-12. doi: 10.2165/00019053-200017010-00001.
7
Cost effectiveness of the prevention and treatment of deep vein thrombosis and pulmonary embolism.深静脉血栓形成和肺栓塞防治的成本效益
Pharmacoeconomics. 1997 Jul;12(1):17-29. doi: 10.2165/00019053-199712010-00003.
8
Prophylaxis for venous thromboembolism in hip fracture surgery: total costs and cost effectiveness in The Netherlands.髋部骨折手术中静脉血栓栓塞的预防:荷兰的总成本及成本效益
Pharmacoeconomics. 1994 Jan;5(1):48-55. doi: 10.2165/00019053-199405010-00007.
9
Prevention and treatment of venous thromboembolism.静脉血栓栓塞症的预防与治疗。
Drugs. 1996 Jul;52(1):71-92. doi: 10.2165/00003495-199652010-00006.
10
Mammographic screening: measurement of the cost in a population based programme in Victoria, Australia.乳腺钼靶筛查:澳大利亚维多利亚州一项基于人群的项目中的成本测算
J Epidemiol Community Health. 1994 Aug;48(4):391-9. doi: 10.1136/jech.48.4.391.

本文引用的文献

1
Incidences of fatal postoperative pulmonary embolism after prophylaxis with dextran 70 and low-dose heparin: an international multicentre study.右旋糖酐70和小剂量肝素预防术后致命性肺栓塞的发生率:一项国际多中心研究。
Br Med J. 1980 Jan 12;280(6207):69-72. doi: 10.1136/bmj.280.6207.69.
2
Advances and controversies in the diagnosis, prevention, and treatment of venous thromboembolism.静脉血栓栓塞症诊断、预防及治疗的进展与争议
Prog Hematol. 1981;12:73-123.
3
Cost effectiveness of clinical diagnosis, venography, and noninvasive testing in patients with symptomatic deep-vein thrombosis.有症状的深静脉血栓形成患者的临床诊断、静脉造影和非侵入性检测的成本效益
N Engl J Med. 1981 Jun 25;304(26):1561-7. doi: 10.1056/NEJM198106253042602.
4
Prophylaxis of venous thromboembolism: analysis of cost effectiveness.静脉血栓栓塞的预防:成本效益分析
Ann Surg. 1980 Feb;191(2):207-18. doi: 10.1097/00000658-198002000-00013.
5
The detection of venous thrombosis of the legs using 125-I-labelled fibrinogen.使用125-I标记的纤维蛋白原检测腿部静脉血栓形成。
Br J Surg. 1968 Oct;55(10):742-7. doi: 10.1002/bjs.1800551007.
6
Prevention of early postoperative deep vein thrombosis by intermittent compression of the leg during surgery.手术期间通过间歇性腿部压迫预防术后早期深静脉血栓形成。
Br Med J. 1971 Nov 13;4(5784):394-6. doi: 10.1136/bmj.4.5784.394.
7
Prevention of postoperative deep vein thrombosis in patients with malignant disease.恶性疾病患者术后深静脉血栓形成的预防
Br Med J. 1974 Mar 2;1(5904):358-60. doi: 10.1136/bmj.1.5904.358.
8
125-I-labelled fibrinogen test adapted for routine screening for deep-vein thrombosis.用于深静脉血栓形成常规筛查的125-I标记纤维蛋白原试验。
Lancet. 1970 Mar 14;1(7646):540-2. doi: 10.1016/s0140-6736(70)90769-5.
9
Prevention of venous thrombosis with small, subcutaneous doses of heparin.
JAMA. 1976 May 3;235(18):1980-2.
10
Treatment of venous thromboembolic disease.静脉血栓栓塞性疾病的治疗
Semin Thromb Hemost. 1976 Apr;2(4):291-331.